Axsome Therapeutics Inc (AXSM)
99.56
-0.92
(-0.92%)
USD |
NASDAQ |
Dec 04, 16:00
99.40
-0.16
(-0.17%)
After-Hours: 20:00
Axsome Therapeutics Gross Profit Margin (Quarterly): 91.95% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 91.95% |
| June 30, 2024 | 90.76% |
| March 31, 2024 | 91.60% |
| December 31, 2023 | 89.69% |
| September 30, 2023 | 88.70% |
| Date | Value |
|---|---|
| June 30, 2023 | 90.15% |
| March 31, 2023 | 92.01% |
| December 31, 2022 | 90.60% |
| September 30, 2022 | 88.58% |
| June 30, 2022 | 88.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
88.58%
Minimum
Sep 2022
92.01%
Maximum
Mar 2023
90.29%
Average
90.38%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Repligen Corp | 50.03% |
| Pfizer Inc | 70.27% |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -194.3% |
| Return on Assets | -54.66% |
| Return on Invested Capital | -91.79% |
| Profit Margin (Quarterly) | -61.67% |
| Operating Margin (Quarterly) | -44.13% |
| Return on Net Operating Assets | -164.7% |